Calcutta HC Denies Abhishek Banerjee Immediate Relief in DJ Remark Voice Sample Case  ||  Bombay High Court Grants Bombay Group Relief in Vadilal Dispute Against Ahmedabad Group  ||  Kerala HC Orders Time-Bound Disposal of Prisoners' Remission Pleas, Mandates NALSA SOP Compliance  ||  Delhi HC Rejects Plea of Two Army Doctors Seeking NEET PG 2026 Exam Amid Eligibility Rule Challenge  ||  Jharkhand HC: Mother Cannot Consent to a Major Son's DNA Test During a Pending Matrimonial Case  ||  Bombay HC Rules on Whether Arrest is Illegal if Co-Accused Charge Sheet is Not Supplied Earlier  ||  Gujarat HC: State Cannot Indefinitely Reserve Private Land Without Acquisition or Plan Revision  ||  Chhattisgarh HC: Complaints Without Disciplinary Action Cannot Affect a Judge's Seniority  ||  Delhi HC Upholds Selection of India's Dressage Team For the 2026 Asian Games  ||  MP High Court Orders State to Airlift Gas Pipeline Blast Victim to Ahmedabad For Treatment    

Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets - (22 Dec 2015)

Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty Pharma Collection Trust to settle and dismissed outstanding patent litigation related to Glenmark's Abbreviated New Drug Application.

Tags : GLENMARK PHARMACEUTICALS INC   FOREST LABORATORIES   LLC   FOREST LABORATORIES HOLDINGS     ROYALTY PHARMA COLLECTION TRUST  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved